Real world use of B-domain-deleted, porcine-sequence factor VIII (RPFVIII) in patients with acquired hemophilia A (AHA): post-marketing safety (PMS) studies in European Union (EU) and in the United States (US)

被引：0
|
作者：
Crea, R. [1 ]
Huang, J. -F. [2 ]
机构：
[1] Shire, Vienna, Austria
[2] Shire, Cambridge, MA USA
来源：
HAEMOPHILIA | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P181
引用
收藏
页码：120 / 120
页数：1
相关论文
共 7 条
  • [1] REAL-WORLD SAFETY AND EFFECTIVENESS OF RECOMBINANT B-DOMAIN-DELETED PORCINE-SEQUENCE FACTOR VIII FOR ACQUIRED HEMOPHILIA A
    Miesbach, W.
    Curry, N.
    Knoebl, P.
    Percy, C.
    Santoro, R.
    Schmaier, A. H.
    Trautmann-Grill, K.
    Badejo, K.
    Chen, J.
    Nouri, M.
    Oberai, P.
    Klamroth, R.
    HAEMOPHILIA, 2023, 29 : 101 - 102
  • [2] REAL-WORLD SAFETY AND EFFECTIVENESS OF RECOMBINANT B-DOMAIN-DELETED PORCINE-SEQUENCE FACTOR VIII FOR ACQUIRED HEMOPHILIA A
    Miesbach, W.
    Knoebl, P.
    Santoro, R.
    Chen, J.
    Tripkovic, N.
    Percy, C. L.
    Schmaier, A. H.
    Klamroth, R.
    HAEMOPHILIA, 2021, 27 : 119 - 119
  • [3] SAFETY AND EFFECTIVENESS OF RECOMBINANT B-DOMAIN-DELETED PORCINE-SEQUENCE FACTOR VIII FOR ACQUIRED HEMOPHILIA A IN A REAL-WORLD SETTING
    Miesbach, W.
    Knoebl, P.
    Santoro, R.
    Chen, J.
    Kemenyash, N.
    Badejo, K. A.
    Percy, C.
    Schmaier, A. H.
    Klamroth, R.
    HAEMOPHILIA, 2022, 28 : 87 - 87
  • [4] United States Post-Marketing Safety (PMS) Study of rpFVIII in Patients with Acquired Hemophilia A: Preliminary Data
    Crea, R.
    Huang, Jui-Fu
    Bajwa, Naghmana
    Gringeri, Alessandro
    BLOOD, 2017, 130
  • [5] POST-MARKETING SAFETY STUDIES OF RECOMBINANT PORCINE FACTOR VIII IN THE UNITED STATES AND EUROPEAN UNION
    Crea, Roberto
    Mauric, Oliver
    Huang, Jui-Fu
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (09) : E13 - E13
  • [6] Safety and Efficacy of B-domain Deleted Third Generation Recombinant Factor VIII (GreenGene F™) in Korean Patients with Hemophilia A: Data from a Post-marketing Surveillance Study
    Kim, Soon Ki
    Yoo, Ki Young
    Lee, Kun Soo
    Hwang, Taiju
    Choi, Yong Mook
    Choi, Eun Jin
    Park, Sang Kyu
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2018, 33 (01)
  • [7] A post-marketing surveillance study of the safety and efficiacy of ReFacto® (Moroctocog Alfa, B-Domain deleted recombinant factor VIII) St. Louis-derived active substance in the treatment and prevension of bleeding episodes in hemophilia A patients.
    Feingold, JM
    Smith, MP
    Littlewood, R
    Giangrande, P
    BLOOD, 2004, 104 (11) : 847A - 848A
1